<p>The Advisory Committee on Immunization Practices (ACIP) has released its 2024 Recommended Adult Immunization Schedule that includes four new vaccines. This year, the Schedule includes the respiratory syncytial virus (RSV) vaccine, the mpox vaccine, a new MenACWY-MenB combo vaccine, and updated versions of the COVID vaccine with both an mRNA and a protein-based adjuvanted formulation. The authors say this year’s Schedule is particularly important because many adults are not up-to-date on recommended vaccines. The complete Schedule, including changes in the vaccine notes section, is published simultaneously in <em>Annals of Internal Medicine</em> and in the Center for Disease Control and Prevention’s (CDC) <em>Morbidity and Mortality Weekly Report</em> (MMWR). </p>
With the new Covid-19 vaccine, experts are sharing five important facts to know, such as its booster status, who needs to it and its possible side effects.
During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.
This report describes the Advisory Committee on Immunization Practices recommendation that all people aged 6 months and older get an updated COVID-19 vaccine.